跳至主要内容
临床试验/JPRN-UMIN000000883
JPRN-UMIN000000883已完成1 期

Phase I Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan(FOLFOXIRI) for Metastatic or Reccurence Colorectal Cancer - FOLFOXIRI(P-I)

Department of Clinical Oncology, Conprehensive Cancer Center, Saitama Medical University International Medical Center0 个研究点目标入组 10 人开始时间: 2007年11月8日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Severe infection 2. 3. History of Irinotecan, and Oxaliplatin use 4. Severe complication 5. 6. Regular use of 7. History of thromboembolism 8. Unmanageable hyper tention 9. Active ulcer 10. Symptomatic brain metastasis 11. 12. 13. 14. History of radiotherapy 15. Massive pleural effusion required drainage 16. Persistent diarrhea 17. 18. 19. HBs antigen and HCV antigen positive 20. Pregnancy or the desire to preserve fecundity 21. 22. Psychological disease deemed to unacceptable for inclusion to the study 23. 24. Inadequate physical condition, as diagnosed by primary physician

研究者

发起方
Department of Clinical Oncology, Conprehensive Cancer Center, Saitama Medical University International Medical Center

相似试验